
Sign up to save your podcasts
Or
AbbVie buys Allergan for $63 billion in cash and stock. Jason Moser analyzes the pros and cons of the deal. Warren Buffett denies any tension between Berkshire-Hathaway and 3G Capital but, would anyone blame him if there was tension? Plus, Jason shares highlights from his trip to Costa Rica and five stock ideas the trip inspired.
4.7
16041,604 ratings
AbbVie buys Allergan for $63 billion in cash and stock. Jason Moser analyzes the pros and cons of the deal. Warren Buffett denies any tension between Berkshire-Hathaway and 3G Capital but, would anyone blame him if there was tension? Plus, Jason shares highlights from his trip to Costa Rica and five stock ideas the trip inspired.
1,650 Listeners
4,085 Listeners
1,756 Listeners
497 Listeners
3,195 Listeners
826 Listeners
657 Listeners
3,369 Listeners
805 Listeners
939 Listeners
1,394 Listeners
1,029 Listeners
9,607 Listeners
885 Listeners
563 Listeners
550 Listeners
43 Listeners